METTL3 and neoplasm: A recent study reveals that EBV EBNA1 promotes the degradation of the METTL3 protein via the K48-linked ubiquitin pathway, decreasing TLR9 m6A modification and YTHDF1-enhanced translation, thus promoting tumor immune evasion [68] (Table 2).